Clene Inc. Profile Avatar - Palmy Investing

Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, incl…

Biotechnology
US, Salt Lake City [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Clene Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Clene Inc. can't present revenue by segment

End of CLNN's Analysis
CIK: 1822791 CUSIP: 185634102 ISIN: US1856341029 LEI: - UEI: -
Secondary Listings
CLNN has no secondary listings inside our databases.